ScreenPro Security Inc. (SCRSF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 207.03 Thousand USD | 132.59% |
| 2022 | 89.01 Thousand USD | -6.82% |
| 2021 | 95.52 Thousand USD | 2.22% |
| 2020 | 93.45 Thousand USD | 87.71% |
| 2019 | 49.78 Thousand USD | 312.99% |
| 2018 | 12.05 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 116.55 Thousand USD | -42.36% |
| 2024 Q2 | 106.76 Thousand USD | 78.22% |
| 2023 Q3 | 45.65 Thousand USD | -26.43% |
| 2023 FY | 207.03 Thousand USD | 132.59% |
| 2023 Q4 | 207.03 Thousand USD | 353.47% |
| 2023 Q2 | 62.05 Thousand USD | -17.63% |
| 2023 Q1 | 75.34 Thousand USD | -15.36% |
| 2022 Q3 | 422.42 Thousand USD | -8.89% |
| 2022 Q1 | 87.38 Thousand CAD | 53.89% |
| 2022 Q4 | 89.01 Thousand USD | -78.93% |
| 2022 FY | 89.01 Thousand USD | -6.82% |
| 2022 Q2 | 463.62 Thousand CAD | 430.57% |
| 2021 Q2 | - CAD | 0.0% |
| 2021 Q1 | - CAD | -100.0% |
| 2021 Q4 | 56.78 Thousand USD | 0.0% |
| 2021 FY | 95.52 Thousand USD | 2.22% |
| 2021 Q3 | - CAD | 0.0% |
| 2020 Q3 | 95.69 Thousand CAD | 10.38% |
| 2020 Q2 | 86.69 Thousand CAD | 11.58% |
| 2020 Q1 | 77.69 Thousand CAD | 13.1% |
| 2020 FY | 93.45 Thousand USD | 87.71% |
| 2020 Q4 | 132.17 Thousand CAD | 38.12% |
| 2019 Q4 | 68.69 Thousand CAD | 0.0% |
| 2019 FY | 49.78 Thousand USD | 312.99% |
| 2018 FY | 12.05 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.24 Million USD | 90.757% |
| Arrayit Corporation | 1.07 Million USD | 80.798% |
| Atlantic International Corp. | 2.93 Million USD | 92.935% |
| Biocept, Inc. | 12.1 Million USD | 98.29% |
| Bioqual, Inc. | 3.58 Million USD | 94.228% |
| CardioGenics Holdings Inc | 72.61 Thousand USD | -185.116% |
| DermTech, Inc. | 54.39 Million USD | 99.619% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 471.86 Million USD | 99.956% |
| HTG Molecular Diagnostics, Inc. | 4.83 Million USD | 95.717% |
| iMD Companies, Inc. | 1.12 Million USD | 81.517% |
| IDenta Corp. | 789.14 Thousand USD | 73.765% |
| Interpace Biosciences, Inc. | 11.19 Million USD | 98.15% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | 43.84 Thousand USD | -372.195% |
| Lumos Diagnostics Holdings Limited | 8.04 Million USD | 97.427% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 3.82 Million USD | 94.589% |
| NovelStem International Corp. | 3.57 Million USD | 94.208% |
| Optigenex Inc. | 8.94 Million USD | 97.684% |
| PharmChem, Inc. | 77.35 Thousand USD | -167.648% |
| Proteome Sciences plc | 17.15 Million USD | 98.793% |
| Response Genetics, Inc | 6.37 Million USD | 96.751% |
| Rennova Health, Inc. | 15.32 Million USD | 98.649% |
| RushNet, Inc. | 4.82 Million USD | 95.707% |
| Stella Diagnostics Inc. | 6.2 Million USD | 96.661% |
| StageZero Life Sciences Ltd. | 1.8 Million USD | 88.499% |
| Todos Medical Ltd. | 38.34 Million USD | 99.46% |